Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: Male

Summary

Study Design : multi-center, double-blind, placebo-controlled, randomized,

parallel group, fixed dose design

Phase : Phase III

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dong-A Pharmaceutical Co., Ltd.
• Treatments: Udenafil

Criteria

Inclusion Criteria:

• Male patients aged 20 years or more diagnosed with ED

Exclusion Criteria:

• Had uncontrolled blood pressure

• Had hepatic or renal dysfunction

• Was currently under anticancer chemotherapy

• Had a treatments for ED using other PDE-5 inhibitors